These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6165428)

  • 1. Toxicity of interferon.
    Scott GM; Secher DS; Flowers D; Bate J; Cantell K; Tyrrell DA
    Br Med J (Clin Res Ed); 1981 Apr; 282(6273):1345-8. PubMed ID: 6165428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of human interferon by antibody affinity chromatography, using highly absorbed anti-interferon.
    Berg K; Heron I; Hamilton R
    Scand J Immunol; 1978; 8(5):429-36. PubMed ID: 725535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon: pharmacokinetics and toxicity.
    Scott GM
    Philos Trans R Soc Lond B Biol Sci; 1982 Sep; 299(1094):91-107. PubMed ID: 6183699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity chromatography of mouse interferon: a modified purification procedure utilizing specifically purified antibodies.
    Hajnická V; Fuchsberger N; Borecký L
    Acta Virol; 1976 Aug; 20(4):326-33. PubMed ID: 9822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin reactions to interferon inoculations are reduced but not abolished by purification.
    Scott GM; Stewart WE; Tyrrell DA; Cantell K; Cartwright T; Edy VG
    J Interferon Res; 1980; 1(1):79-86. PubMed ID: 6180048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential antibody affinity chromatography of human leukocyte interferon.
    Berg K
    Scand J Immunol; 1977; 6(1-2):77-86. PubMed ID: 847400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of human leukocyte interferon.
    Cantell K; Pyhälä L
    J Infect Dis; 1976 Jun; 133 Suppl():A6-12. PubMed ID: 932506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of human interferons by antibody affinity chromatography.
    Berg K; Alacam R; Hamilton RD; Heron I
    Tex Rep Biol Med; 1977; 35():187-92. PubMed ID: 358447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper chelate affinity chromatography of human fibroblast and leucocyte interferons.
    Chadha KC; Grob PM; Mikulski AJ; Davis LR; Sulkowski E
    J Gen Virol; 1979 Jun; 43(3):701-6. PubMed ID: 479851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of human leukocyte interferon in patients with advanced cancer.
    Horning SJ; Levine JF; Meyer M; Merigan TC; Rosenberg SA
    J Biol Response Mod; 1983; 2(1):47-56. PubMed ID: 6196450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinity chromatography of human leukocyte and diploid cell interferons on sepharose-bound antibodies.
    Berg K; Ogburn CA; Paucker K; Mogensen KE; Cantell K
    J Immunol; 1975 Feb; 114(2 Pt 1):640-4. PubMed ID: 1168221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial purification of human interferon by affinity chromatography.
    Anfinsen CB; Bose S; Corley L; Gurari-Rotman D
    Proc Natl Acad Sci U S A; 1974 Aug; 71(8):3139-42. PubMed ID: 4370251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Isolation of purified and concentrated human interferon from Namalwa cells].
    Mel'nikova NL; Shukhmina NR; Pille ER; Zverev VV; Isaevich LV; Kuz'mina TI; Shchipanova AI; Maĭchuk IuF; Andzhaparidze OG
    Vopr Virusol; 1989; 34(6):711-4. PubMed ID: 2483780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity studies with human leukocyte interferon in newborn rabbits.
    Pyhälä L; Rimaila-Pärnänen E; Kekomäki R; Kostiainen E; Cantell K
    Acta Pathol Microbiol Scand C; 1978 Apr; 86(2):45-51. PubMed ID: 696330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I evaluation of a synthetic mutant of beta-interferon.
    Hawkins M; Horning S; Konrad M; Anderson S; Sielaff K; Rosno S; Schiesel J; Davis T; DeMets D; Merigan T
    Cancer Res; 1985 Nov; 45(11 Pt 2):5914-20. PubMed ID: 4053062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interim report on studies on "toxic" effects of human leucocyte-derived interferon-alpha (HuIFN-alpha).
    Scott GM; Wallace J; Tyrrell DA; Cantell K; Secher DS; Stewart WE
    J Interferon Res; 1982; 2(1):127-30. PubMed ID: 6180101
    [No Abstract]   [Full Text] [Related]  

  • 17. [The chromophore of blue dextran: a powerful ligand for the purification of interferon by affinity chromatography].
    de Maeyer-Guignard J; de Maeyer E
    C R Acad Hebd Seances Acad Sci D; 1976 Sep; 283(6):709-11. PubMed ID: 825322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of vaccinia lesions in Rhesus monkeys by human leucocyte and fibroblast interferon.
    Weimar W; Stitz L; Billiau A; Cantell K; Schellekens H
    J Gen Virol; 1980 May; 48(1):25-30. PubMed ID: 6155433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An immunosorbent for interferon purification].
    Garipova MI; Monakov IuB; Baschenko IA; Frolova IS; Kleeva OB; Kuznetsov VP
    Vopr Virusol; 1993; 38(3):129-32. PubMed ID: 7521101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating interferon in man after administration of exogenous human leukocyte interferon.
    Emödi G; Just M; Hernandez R; Hirt HR
    J Natl Cancer Inst; 1975 May; 54(5):1045-9. PubMed ID: 1127735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.